These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 15969002)

  • 1. [Cytokine aptamers as therapeutic and diagnostic agents].
    Yan XR; Gao XW; Zhang ZQ
    Sheng Wu Gong Cheng Xue Bao; 2004 Jul; 20(4):627-32. PubMed ID: 15969002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aptamers as therapeutic and diagnostic agents.
    Brody EN; Gold L
    J Biotechnol; 2000 Mar; 74(1):5-13. PubMed ID: 10943568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aptamers: a new class of oligonucleotides in the drug discovery pipeline?
    Dausse E; Da Rocha Gomes S; Toulmé JJ
    Curr Opin Pharmacol; 2009 Oct; 9(5):602-7. PubMed ID: 19717337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent Advances in SELEX Technology and Aptamer Applications in Biomedicine.
    Zhuo Z; Yu Y; Wang M; Li J; Zhang Z; Liu J; Wu X; Lu A; Zhang G; Zhang B
    Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29036890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA aptamers: a review of recent trends and applications.
    Kang KN; Lee YS
    Adv Biochem Eng Biotechnol; 2013; 131():153-69. PubMed ID: 22491855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SELEX Modifications and Bioanalytical Techniques for Aptamer-Target Binding Characterization.
    Tan SY; Acquah C; Sidhu A; Ongkudon CM; Yon LS; Danquah MK
    Crit Rev Anal Chem; 2016 Nov; 46(6):521-37. PubMed ID: 26980177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advancements in Aptamer Discovery Technologies.
    Gotrik MR; Feagin TA; Csordas AT; Nakamoto MA; Soh HT
    Acc Chem Res; 2016 Sep; 49(9):1903-10. PubMed ID: 27526193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Technology evaluation: SELEX, Gilead Sciences Inc.
    Sun S
    Curr Opin Mol Ther; 2000 Feb; 2(1):100-5. PubMed ID: 11249646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SELEX methods on the road to protein targeting with nucleic acid aptamers.
    Bayat P; Nosrati R; Alibolandi M; Rafatpanah H; Abnous K; Khedri M; Ramezani M
    Biochimie; 2018 Nov; 154():132-155. PubMed ID: 30193856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aptamers and SELEX in Chemistry & Biology.
    Famulok M; Mayer G
    Chem Biol; 2014 Sep; 21(9):1055-8. PubMed ID: 25237853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in SELEX and application of aptamers in the central nervous system.
    Yang Y; Yang D; Schluesener HJ; Zhang Z
    Biomol Eng; 2007 Dec; 24(6):583-92. PubMed ID: 17681489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An improved SELEX technique for selection of DNA aptamers binding to M-type 11 of Streptococcus pyogenes.
    Hamula CL; Peng H; Wang Z; Tyrrell GJ; Li XF; Le XC
    Methods; 2016 Mar; 97():51-7. PubMed ID: 26678795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated microfluidic system for rapid screening of CRP aptamers utilizing systematic evolution of ligands by exponential enrichment (SELEX).
    Huang CJ; Lin HI; Shiesh SC; Lee GB
    Biosens Bioelectron; 2010 Mar; 25(7):1761-6. PubMed ID: 20061133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A simple method for eliminating fixed-region interference of aptamer binding during SELEX.
    Ouellet E; Lagally ET; Cheung KC; Haynes CA
    Biotechnol Bioeng; 2014 Nov; 111(11):2265-79. PubMed ID: 24895227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A two-step stimulus-response cell-SELEX method to generate a DNA aptamer to recognize inflamed human aortic endothelial cells as a potential in vivo molecular probe for atherosclerosis plaque detection.
    Ji K; Lim WS; Li SF; Bhakoo K
    Anal Bioanal Chem; 2013 Aug; 405(21):6853-61. PubMed ID: 23842900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SELEX--a (r)evolutionary method to generate high-affinity nucleic acid ligands.
    Stoltenburg R; Reinemann C; Strehlitz B
    Biomol Eng; 2007 Oct; 24(4):381-403. PubMed ID: 17627883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aptamers against extracellular targets for in vivo applications.
    Pestourie C; Tavitian B; Duconge F
    Biochimie; 2005; 87(9-10):921-30. PubMed ID: 15963620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effects of SELEX Conditions on the Resultant Aptamer Pools in the Selection of Aptamers Binding to Bacterial Cells.
    Hamula CL; Peng H; Wang Z; Newbigging AM; Tyrrell GJ; Li XF; Le XC
    J Mol Evol; 2015 Dec; 81(5-6):194-209. PubMed ID: 26538121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of HGF-binding aptamers with the combination of G4 promoter-derived aptamer selection and in silico maturation.
    Yokoyama T; Tsukakoshi K; Yoshida W; Saito T; Teramoto K; Savory N; Abe K; Ikebukuro K
    Biotechnol Bioeng; 2017 Oct; 114(10):2196-2203. PubMed ID: 28627727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in aptamer screening and small molecule aptasensors.
    Kim YS; Gu MB
    Adv Biochem Eng Biotechnol; 2014; 140():29-67. PubMed ID: 23851587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.